The drug sciences are a gathering of interdisciplinary spaces of study worried about the plan, activity, conveyance, and attitude of medications. They apply information from science (inorganic, physical, biochemical, and insightful), science (life systems, physiology, natural chemistry, cell science, and sub-atomic science), the study of disease transmission, measurements, chemometrics, math, physical science, and synthetic designing.

The drug sciences are additionally partitioned into a few explicit fortes, with four primary branches:

• Pharmacology:  The investigation of the biochemical and physiological impacts of medications on individuals.

• Pharmacodynamics:  The investigation of the cell and sub-atomic connections of medications with their receptors. Just "How the medication deals with the body"

• Pharmacokinetics:  The investigation of the components that control the grouping of medication at different destinations in the body. Essentially "How the body deals with the medication"

• Pharmaceutical toxicology: The investigation of the destructive or poisonous impacts of medications.

• Pharmacogenomics:  The investigation of the legacy of trademark examples of communication among medications and organic entities.

• Pharmaceutical science:  The investigation of medication configuration to enhance pharmacokinetics and pharmacodynamics, and amalgamation of new medication atoms (Medicinal Chemistry).

• Pharmaceutics:  The examination and plan of medication detailing for ideal conveyance, soundness, pharmacokinetics, and patient acknowledgment.

Session 2:  Drug discovery

This research topic aims to publish data on recent advances in early Drug Discovery against emerging/neglected tropical diseases, including parasitic, bacterial, viral, and fungal infections Here, we gather insightful data on the creation of fresh experimental methods, the discovery of fresh therapeutic plans, and the mode of action of traditional or cutting-edge antibacterial substances.

Over the past 40 years, the complexity of drug development has multiplied, necessitating the preclinical stage of drug research, an investigational new drug (IND) application, and extensive clinical testing before FDA marketing clearance. Successful  Drug Discovery is like finding a safe and effective oasis in a chemical and biological desert. Because deserts are huge and oases are tiny, analyses based on the drug development strategy reveal that the discoverability of viable candidates is extremely sensitive to the accuracy of predictions. Especially since  Drug Discovery is very difficult to measure late in the process before the project succeeds or fails.

    Discovery Development
    Preclinical research
    Drug development process
    Market  monitoring

Session 3: Drug Development

Once a lead molecule has been found through the process of drug discovery, the process of drug development is used to bring a new pharmaceutical medicine to market. Preclinical research on microbes and animals is part of this process, as is requesting regulatory status, such as through the US Food and Drug Administration, to begin human clinical trials for an investigational new drug. It may also include the step of securing regulatory approval with a new drug application to market the drug. It normally takes more than ten years for a vaccine or medication to be approved, from concept to preclinical testing in the lab to clinical trial development, including Phase I-III trials.

Session 4: FDA Drug Review

The structural similarities between the FDA's drug reviews and many other regulatory bodies' judgments include high uncertainty, low reversibility, avoiding observable error, and high political stakes that encourage lobbying by interested parties. This essay investigates the policy implications of considering FDA drug evaluation as a politically motivated information processing activity. I contend that the incentives regulators face place restrictions on how quickly medication reviews may be completed, that these motivations may make privatization efforts difficult, and that political pressures may be helpful in identifying high-priority pharmaceuticals.

·Pharmaceuticals

·Disease

·Politics

·HIV\ AIDS

·Prescription Drug Costs

Session 5:  Drug Discovery and Screening

The Drug Discovery Process involves many different stages and series of actions. Typically, it can be divided into four main stages: Early Drug Discovery, Pre-Clinical Phase, Clinical Phases, and Regulatory Approval. Let's explore the major steps that are taken in each of these stages to develop a new drug.

Drug discovery is a process where a new drug or medication is discovered and aims to identify a compound therapeutically useful in curing and treating disease. It includes a wide range of scientific divisions, including biology, chemistry, and pharmacology. This process associates with the identification of candidates, synthesis, characterization, validation, optimization, screening, and assays for therapeutic efficacy.

Drug screening is a process where potential drugs are identified and optimized before the selection of a candidate drug to progress to clinical trials. It can involve screening large volumes of chemicals for a particular biological activity in high-throughput screening assays. Drug screening mainly includes In-vivo and In-vivo models drug screening.

·Discovery and Development.

·Preclinical Researches

·Clinical Researches

·FDA Review.

· FDA Post-Market Safety Monitoring.

Session 6 : Clinical trial in Drug Discovery

Today, people are living longer because of the success of cancer treatments resulting from previous clinical trials. Through clinical trials and drug discovery, doctors determine whether new treatments are safe, effective, and better than current treatments. Participating in clinical trials broadens our knowledge about cancer and helps improve cancer care for future patients. In this way, clinical trials play a major role in the drug development and Drug Design process.

 Helps improve treatment. Clinical trials are key to advancing the fight against cancer. In today's global scientific age, clinical trials and drug Discovery are essential to bringing newer and better medicines to market. Clinical trials test potential treatments on human volunteers (subjects) to determine whether they should be approved for wider use in the general population. For the future of better healthcare, Clinical Trials are important.

Prevention trials

Treatment trials

case-control studies

Cross-sectional studies

Session 7:  FDA Post-Market Drug Safety Monitoring

Despite the fact that data from clinical trials is crucial for understanding a drug's efficacy and safety, it is difficult to know everything there is to know about a drug's safety at the time of approval. There are restrictions despite the meticulous processes in the drug development process.

 As a result, throughout the weeks, months, and sometimes even years that make up a product's existence on the market, the true image of that product's safety actually changes. When FDA receives reports of concerns with prescription and OTC medications, it may decide to add warnings to the dosage or usage instructions or take other action in the case of more serious problems.

In this session You Will find information on:

·Supplemental Application

·INDs for Market Drugs

·Manufacturer Inspections

·Generic Drugs

·Reporting Problems

Session 8:  History Of Drug Discovery

 Drug discovery and development has a long history and dates back to the early days of human Civilization. The first synthetic drug, chloral hydrate, was discovered in 1869 and introduced as a sedative-hypnotic; it is still available today in some countries. Ancient people in what is now Switzerland ate poppy seeds (the source of opium) in 2500 BCE. Coca leaves (the source of cocaine) have been chewed for thousands of years. Folk medicines made from plants and herbs have also been used since ancient times. People in ancient Palestine drank wine in 350 BCE.

·Chinese Medicine

·Indian  Medicine

·Greek  Medicine

·Roman  Medicine

Session 9: Advanced Drug Delivery System

An advanced drug delivery system is also termed a Novel drug delivery system which improves drug potency, controls drug release to give a sustained therapeutic effect, and provides greater safety then finally it targets a drug specifically to the desired tissue. Drug Delivery systems are developed to deliver a required amount of drugs effectively to appropriate target sites and to maintain the desired drug levels

Innovative Drug Delivery Technologies

Implantable Drug Delivery System

Pediatric Drug Delivery systems

Routes of Drug Administration

Session 10:  Future trends impacting the pharmaceutical industry

Gene and cell therapies could make strong advancements in 2021 providing a new approach to treating diseases. Cancer treatments have been advancing at an accelerated pace, offering clinical benefits and increased specificity through engineered cell or gene therapies. The Indian pharma industry is expected to grow to $130 billion by 2030 and become the leading provider of medicines to the world, said Indian Pharmaceutical Alliance (IPA) Secretary General, Sudarshan Jain on Thursday.

Top  Pharma Trends in 2022

·Artificial Intelligence

·Big Data & Analytics

·Flexible Production.

·Precision Medicine

·Additive Manufacturing

·Blockchain

·Extended Reality (XR)